5.418 empresas correspondem
Showing 3.751–3.800 of 5.418
| Empresa | Nota | Preço | Abaixo da máx. | P/L | Tamanho | Yield | Opções | Setor |
|---|---|---|---|---|---|---|---|---|
| C- | US$ 5,62 | -24% | — | US$ 146,1M | — | Mensais | Medical Devices | |
| F- | US$ 4,79 | -76% | — | US$ 146,1M | — | — | Software Infrastructure | |
| C | US$ 1,03 | -65% | 17,08 | US$ 145,9M | — | Mensais | Specialty Chemicals | |
| F- | US$ 3,15 | -56% | — | US$ 145,5M | 1,3% | Mensais | Insurance Specialty | |
| D- | US$ 5,09 | -45% | — | US$ 145,2M | — | Mensais | Auto Parts | |
| F- | US$ 2,94 | -24% | — | US$ 145,2M | — | Mensais | Information Technology Services | |
| C+ | US$ 47,80 | -32% | 12,29 | US$ 145,2M | 3,1% | — | Electrical Equipment and Parts | |
| F- | US$ 12,86 | -4% | — | US$ 143,8M | — | Mensais | Personal Services | |
| B- | US$ 1,23 | -55% | 40,83 | US$ 143,7M | — | Mensais | Apparel Manufacturing | |
| A | US$ 123,86 | -19% | — | US$ 142,4M | — | Mensais | — | |
| D- | US$ 4,41 | -86% | — | US$ 142,3M | — | Mensais | Computer Hardware | |
| C- | US$ 1,35 | -45% | — | US$ 142,2M | — | Mensais | Biotechnology | |
| A- | US$ 1,78 | -58% | — | US$ 142,1M | — | Mensais | Auto Manufacturers | |
| F | US$ 1,54 | -59% | — | US$ 142M | — | Mensais | Semiconductors | |
| B | US$ 9,56 | -28% | 7,84 | US$ 141,6M | — | Mensais | Reit Office | |
| A+ | US$ 21,92 | -5% | 11,72 | US$ 141,5M | 1,7% | — | Banks Regional | |
| D | US$ 3,89 | -19% | 24,28 | US$ 141,3M | — | Mensais | Apparel Retail | |
| Sem nota | US$ 3,80 | -74% | — | US$ 141,3M | — | Mensais | Biotechnology | |
| F | US$ 3,47 | -26% | — | US$ 140,8M | 13,9% | Mensais | Oil Gas E and P | |
| F- | US$ 1,50 | -41% | — | US$ 140,6M | — | — | Biotechnology | |
| F- | US$ 3,45 | -40% | — | US$ 139,9M | — | Mensais | Auto Parts | |
| D | US$ 4,85 | -59% | — | US$ 139,8M | — | — | Biotechnology | |
| Sem nota | US$ 10,14 | 0% | — | US$ 138,7M | — | — | Shell Companies | |
| F- | US$ 1,26 | -83% | — | US$ 138,6M | — | Mensais | Internet Retail | |
| D | US$ 0,50 | -73% | — | US$ 138,5M | — | Mensais | Drug Manufacturers Specialty and Generic | |
| Sem nota | US$ 9,62 | -43% | — | US$ 138,3M | 3,4% | Mensais | — | |
| C | US$ 12,29 | -51% | — | US$ 137,9M | — | Mensais | Software Infrastructure | |
| C | US$ 1,80 | -60% | — | US$ 137,9M | — | — | Software Application | |
| F | US$ 5,87 | -34% | — | US$ 137,3M | 21,8% | — | Reit Mortgage | |
| B- | US$ 3,10 | -21% | — | US$ 137M | — | Mensais | Pollution and Treatment Controls | |
| D- | US$ 8,95 | -71% | — | US$ 136,6M | — | — | Software Infrastructure | |
| Sem nota | US$ 0,35 | -59% | — | US$ 136,3M | — | — | Scientific and Technical Instruments | |
| D- | US$ 2,87 | -64% | — | US$ 136,3M | — | Mensais | Medical Devices | |
| C- | US$ 4,61 | -72% | — | US$ 134,7M | — | Mensais | Medical Devices | |
| C- | US$ 20,78 | -11% | — | US$ 134,6M | — | — | Specialty Industrial Machinery | |
| F- | US$ 1,34 | -75% | — | US$ 134,4M | — | Mensais | Biotechnology | |
| Sem nota | US$ 14,80 | -41% | — | US$ 134,1M | — | — | — | |
| Sem nota | US$ 11,05 | -9% | — | US$ 134,1M | — | — | — | |
| D+ | US$ 7,36 | -51% | 18,87 | US$ 134M | 1,1% | Mensais | Software Application | |
| B | US$ 4,29 | -21% | — | US$ 133,7M | — | Mensais | Apparel Retail | |
| F | US$ 7,34 | -37% | — | US$ 133,4M | — | Mensais | Telecom Services | |
| F | US$ 4,18 | -50% | — | US$ 132,9M | 22,7% | Mensais | Reit Mortgage | |
| F | US$ 1,24 | -57% | — | US$ 132,9M | — | Mensais | Health Information Services | |
| F- | US$ 1,68 | -94% | — | US$ 132,8M | — | — | Internet Content and Information | |
| C- | US$ 1,30 | -41% | — | US$ 132,8M | — | Mensais | Luxury Goods | |
| F- | US$ 9,77 | -59% | — | US$ 131,4M | — | Mensais | Reit Mortgage | |
| F- | US$ 2,47 | -87% | — | US$ 130,9M | — | — | Software Infrastructure | |
| D- | US$ 3,01 | -5% | — | US$ 130,9M | — | Mensais | Medical Devices | |
| C- | US$ 2,29 | -69% | — | US$ 130,9M | — | Mensais | Biotechnology | |
| D- | US$ 0,99 | -72% | — | US$ 130,4M | 10,1% | Mensais | Business Equipment and Supplies |
Um filtro não é uma recomendação. Cada linha cumpriu o teste indicado e nada mais — a InspectStocks descreve empresas a partir dos próprios documentos entregues à SEC e não aconselha comprar ou vender nada.